Gilead Sciences, Inc. (GILD) Yield on Cost (YOC): 2.54%
The yield on cost (YOC) for Gilead Sciences, Inc. (GILD) is 2.54%.
GILD Yield on Cost (YOC) Metrics
YIELD ON COST (YOC)
2.54%
Forward Yield on Cost Projections
If you buy GILD today at the current stock price of $125.50 with a yield of 2.54% and dividends continue to grow at the historical rate (3.0% CAGR), your YOC would be:
Current Yield
2.54%
YOC in 3 Years
2.83%
YOC in 5 Years
3.04%
YOC in 10 Years
3.63%
Interactive Yield on Cost Calculator
Project custom investment returns for Gilead Sciences, Inc. (GILD) based on your custom cost basis.
Starting Yield
2.54%
Ending YOC
3.98%
Year 15 Dividend
$5.00
Cum. Dividends Recd.
$61.31
| Year | Projected Div. / Share | YoY Dividend Hike | Yield on Cost (YOC) | Total Dividends Recd. |
|---|---|---|---|---|
| Initial | $3.19 | — | 2.54% | $0.00 |
| Year 1 | $3.29 | +3.04% | 2.62% | $3.29 |
| Year 2 | $3.39 | +3.04% | 2.70% | $6.67 |
| Year 3 | $3.49 | +3.04% | 2.78% | $10.16 |
| Year 4 | $3.60 | +3.04% | 2.87% | $13.76 |
| Year 5 | $3.71 | +3.04% | 2.95% | $17.46 |
| Year 6 | $3.82 | +3.04% | 3.04% | $21.28 |
| Year 7 | $3.93 | +3.04% | 3.13% | $25.22 |
| Year 8 | $4.05 | +3.04% | 3.23% | $29.27 |
| Year 9 | $4.18 | +3.04% | 3.33% | $33.45 |
| Year 10 | $4.30 | +3.04% | 3.43% | $37.75 |
| Year 11 | $4.43 | +3.04% | 3.53% | $42.19 |
| Year 12 | $4.57 | +3.04% | 3.64% | $46.76 |
| Year 13 | $4.71 | +3.04% | 3.75% | $51.46 |
| Year 14 | $4.85 | +3.04% | 3.87% | $56.31 |
| Year 15 | $5.00 | +3.04% | 3.98% | $61.31 |
Yield on Cost (YOC) Formula
Formula: Yield on Cost = Annual Dividend / Original Purchase Price × 100
Inputs shown in the projection:
- Original purchase price.
- Annual dividend per share at the starting point.
- Assumed annual dividend growth rate.
- Projected annual dividend divided by original purchase price.
Note: Forward projections assume dividends continue to grow at the designated growth rate. Actual dividend payments are declared by corporate boards and are subject to change.
Gilead Sciences, Inc. Yield on Cost (YOC) Formula & Definition
Yield on Cost shows the dividend yield based on your original purchase price. As dividends grow, your YOC increases even if the market yield stays the same.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Gilead Sciences, Inc. Yield on Cost (YOC) FAQ
- What is the yield on cost (YOC) for Gilead Sciences, Inc. (GILD)?
- The yield on cost (YOC) for GILD stock is 2.54%.
About Gilead Sciences, Inc.
Gilead Sciences, Inc. is a global biopharmaceutical enterprise, with operations spanning the United States, Europe, and numerous international markets. Its core mission involves discovering, developing, and commercializing innovative medications to address critical health needs. The company's extensive product portfolio encompasses treatments for a variety of severe conditions. For HIV/AIDS, it supplies key therapies such as Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/Eviplera, Stribild, and Atripla. In response to the 2019 coronavirus pandemic, Gilead provides Veklury, an injectable drug for intravenous administration. Its offerings for liver diseases include Epclusa, Harvoni, Vosevi, Vemlidy, and Viread. Furthermore, Gilead assists patients battling hematological disorders, various cancers, and those undergoing cell therapy, through products like Yescarta, Tecartus, Trodelvy, and Zydelig. Other specialized medicines include Letairis, an oral drug for pulmonary arterial hypertension; Ranexa, also an oral medication, for chronic angina; and AmBisome, a liposomal formulation designed to combat serious invasive fungal infections. Gilead Sciences, Inc. actively engages in collaboration agreements with a diverse range of partners to advance its therapeutic pipeline. These include Arcus Biosciences, Inc., Pionyr Immunotherapeutics Inc., Tizona Therapeutics, Inc., Tango Therapeutics, Inc., Jounce Therapeutics, Inc., Galapagos NV, Janssen Sciences Ireland Unlimited Company, Japan Tobacco, Inc., Gadeta B.V., Bristol-Myers Squibb Company, Dragonfly Therapeutics, Inc., and Merck & Co, Inc. The company was founded in 1987 and its corporate headquarters are situated in Foster City, California.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Daniel O'Day